As shown in Figure 7(e), HBE inhibited the activation of the syntenin/STAT3 pathway by reducing the expression of syntenin and phosphorylation of STAT3 at Y705 and modulated the expression of EMT-related proteins to inhibit the metastasis of GC. Here, STAT3 is linked to gastric cancer.